Header Logo
Newsletter Podcast
Log In
← Back to all posts

Lasting Relief, Better Outcomes—Plus What PRP Docs Are Doing Differently

Apr 29, 2025
Connect

Highlights

  • Today’s Research Article: Your go-to treatment just got outperformed—see why PRP is leading in joint relief.

  • Questions from the Field: Even if they’re under 65, it’s better to have the ABN signed—every time.

  • Let’s Get Down to Business: Educate, personalize, and document—keys to building a thriving PRP practice.

  • Come Join Us: Train smarter, connect deeper—your next breakthrough starts at a live event.

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Platelet-Rich Plasma versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis: A Prospective Randomized Controlled Clinical Trial

Michael-Alexander Malahias, Leonidas Roumeliotis, Vasileios S. Nikolaou, Efstathios Chronopoulos, Ioannis Sourlas, and Georgios C. Babis

Read the full article here.

Summary:

This prospective randomized controlled trial by Malahias et al. compared intra-articular platelet-rich plasma (IA-PRP) injections with corticosteroid injections for treating early to moderate trapeziometacarpal (thumb base) arthritis. Over 12 months, patients receiving IA-PRP experienced significantly better outcomes in pain relief (VAS score), hand function (Q-DASH score), and satisfaction than those treated with corticosteroids. While both treatments showed improvement at 3 months, only the PRP group maintained and improved these benefits at 12 months, with 62.5% of PRP patients reporting mild pain vs. just 12.5% in the steroid group.

The study also demonstrated that patient satisfaction with PRP rose over time, reaching 69% at 12 months compared to only 12.5% in the steroid group. This sustained improvement is attributed to PRP’s biological effects, including anti-inflammatory properties and stimulation of cartilage repair. Given its longer-lasting relief and functional improvement, IA-PRP offers a superior non-surgical option for managing mild to moderate thumb arthritis compared to the short-lived effects of corticosteroids.

Doctor-to-Patient Talking Points for Choosing IA-PRP Over Steroids (with Evidence)

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
PRP’s edge on back pain, smarter marketing, and a live demo invite
Highlights Today’s Research Article: PRP outlasts steroids—stronger, safer, longer relief for back pain. Questions from the Field: From blood draw to injection: PRP takes just 20–25 minutes. Let’s Get Down to Business: Marketing isn’t sales—it’s how patients discover you. Come Join Us: See PRP in action—live demo & Q&A with Dr. Ariana DeMers.   If this newsletter was forwarded to you and you...
Stronger Shoulders, Smarter PRP, Better Marketing
Highlights Today’s Research Article: PRP beats PT in restoring shoulder function—lasting results without surgery. Questions from the Field: Not all PRP systems are equal—know your spin, know your outcomes. Let’s Get Down to Business: Doctors shouldn’t market alone—team up and thrive in today’s digital age. Come Join Us: Turn orthobiologic knowledge into profit at BOB Live—your Monday-r...
Grade IV OA? PRP Delivers – Plus, What to Do When Patients Don’t Respond
Highlights Today’s Research Article: Grade IV knee arthritis patients move better, hurt less, and skip the scalpel. Questions from the Field: When PRP results fall short, smart testing and re-dosing can turn non-responders into success stories. Let’s Get Down to Business: Connect, refer, and watch your practice grow. Come Join Us: BOB Live turns knowledge into profit   Turn what you...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.